Summary by Moomoo AI
Trifolium Biopharma Limited (Trifolium Bio-B) submitted the latest Securities Subscription Monthly Return to the Hong Kong Exchanges and Clearing Limited on October 7, 2024, reporting the share changes as of September 30, 2024. The report indicates that the company's authorized/registered share capital and issued shares (excluding treasury shares) remained unchanged during the reporting period, staying at 2,000,000,000 common shares with a par value of $0.0001 per share, totaling an authorized/registered share capital of $200,000 and total issued shares of 1,297,048,929 shares. Furthermore, in the company's share options scheme, the number of share options for pre-IPO share option scheme and post-IPO share option scheme are 1,848,817 shares and 30,091,988 shares respectively, with no new share options exercised this month and no share options expired or canceled. Overall, the share structure of Trifolium Bio-B remained stable during that month.
